IL4 and neoplasm: Interleukin-4(IL-4), produced by activated Th2 type CD4+ T cells, represents a key differentiation cytokine that induces development of Th2 subset of lymphocytes, which is responsible for surveillance and clearance of tumor cells by activation of granulocytes and eosinophils, as well as inhibition of angiogenesis [6,7].